InvestorsHub Logo
Followers 10
Posts 605
Boards Moderated 0
Alias Born 06/30/2014

Re: None

Thursday, 12/05/2019 8:34:18 AM

Thursday, December 05, 2019 8:34:18 AM

Post# of 513
Another one bites the dust: SAGE
Did well in phase 2, a cautionary tale

Sage Therapeutics' SAGE-217 flunks MDD study; shares down 60%

https://apple.news/AQumOSsppQJKjbcx5kPe12w
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RLMD News